Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 9.53 Million CNY | 125.55% |
| 2022 | -37.31 Million CNY | -59.85% |
| 2021 | -23.34 Million CNY | 65.28% |
| 2020 | -67.22 Million CNY | -344.59% |
| 2019 | 27.48 Million CNY | -54.88% |
| 2018 | 60.9 Million CNY | -5.58% |
| 2017 | 64.5 Million CNY | 5.32% |
| 2016 | 61.24 Million CNY | -3.27% |
| 2015 | 63.31 Million CNY | 124.6% |
| 2014 | 28.19 Million CNY | -38.55% |
| 2013 | 45.87 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.62 Million CNY | -68.82% |
| 2024 Q2 | 140.59 Thousand CNY | -91.34% |
| 2024 Q3 | -5.45 Million CNY | -3981.97% |
| 2023 Q1 | 3.19 Million CNY | 108.2% |
| 2023 Q3 | 1.33 Million CNY | 737.0% |
| 2023 Q2 | -209.83 Thousand CNY | -106.56% |
| 2023 Q4 | 5.2 Million CNY | 289.74% |
| 2023 FY | 9.53 Million CNY | 125.55% |
| 2022 FY | -37.31 Million CNY | -59.85% |
| 2022 Q4 | -39 Million CNY | -6144.36% |
| 2022 Q3 | 645.38 Thousand CNY | 381.58% |
| 2022 Q2 | -229.2 Thousand CNY | -117.89% |
| 2022 Q1 | 1.28 Million CNY | 103.64% |
| 2021 Q3 | 2.38 Million CNY | -67.56% |
| 2021 Q4 | -35.14 Million CNY | -1573.39% |
| 2021 Q1 | 2.06 Million CNY | 104.52% |
| 2021 FY | -23.34 Million CNY | 65.28% |
| 2021 Q2 | 7.35 Million CNY | 256.3% |
| 2020 Q4 | -45.65 Million CNY | -446.36% |
| 2020 Q3 | -8.35 Million CNY | -47.88% |
| 2020 Q2 | -5.65 Million CNY | 25.28% |
| 2020 Q1 | -7.56 Million CNY | -188.07% |
| 2020 FY | -67.22 Million CNY | -344.59% |
| 2019 FY | 27.48 Million CNY | -54.88% |
| 2019 Q4 | 8.58 Million CNY | 746.88% |
| 2019 Q3 | -1.32 Million CNY | -107.77% |
| 2019 Q1 | 3.14 Million CNY | -76.8% |
| 2019 Q2 | 17.07 Million CNY | 442.57% |
| 2018 Q1 | 5.61 Million CNY | -68.06% |
| 2018 Q3 | 12.85 Million CNY | -55.48% |
| 2018 Q4 | 13.56 Million CNY | 5.52% |
| 2018 FY | 60.9 Million CNY | -5.58% |
| 2018 Q2 | 28.87 Million CNY | 414.52% |
| 2017 Q4 | 17.57 Million CNY | 22.04% |
| 2017 FY | 64.5 Million CNY | 5.32% |
| 2017 Q1 | 1.33 Million CNY | -91.52% |
| 2017 Q3 | 14.39 Million CNY | -53.84% |
| 2017 Q2 | 31.19 Million CNY | 2230.62% |
| 2016 Q4 | 15.77 Million CNY | 20.34% |
| 2016 Q3 | 13.1 Million CNY | 0.0% |
| 2016 FY | 61.24 Million CNY | -3.27% |
| 2015 FY | 63.31 Million CNY | 124.6% |
| 2014 FY | 28.19 Million CNY | -38.55% |
| 2013 FY | 45.87 Million CNY | 0.0% |